Floatz logo

Therapeutic Asset Ratings

3,272 results matching 1 filter

91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Olaparib
Rhabdoid Tumor
National Cancer Institute (NCI)P2B (57)
Olaparib
Wilms Tumor
National Cancer Institute (NCI)P2B (57)
Oxodotreotide
Prostate Cancer
National Cancer Institute (NCI)P2B (57)
Palbociclib
Langerhans Cell Histiocytosis
National Cancer Institute (NCI)P2B (57)
Palbociclib
Malignant Glioma
National Cancer Institute (NCI)P2B (57)
Palbociclib
Rectal Carcinoma
National Cancer Institute (NCI)P2B (57)
Palbociclib
Ependymoma
National Cancer Institute (NCI)P2B (57)
Palbociclib
Glioma
National Cancer Institute (NCI)P2B (57)
Palbociclib
Hepatoblastoma
National Cancer Institute (NCI)P2B (57)
Palbociclib
Malignant Germ Cell Tumor
National Cancer Institute (NCI)P2B (57)
Palbociclib
Osteosarcoma
National Cancer Institute (NCI)P2B (57)
Palbociclib
Peripheral Primitive Neuroectodermal Tumor
National Cancer Institute (NCI)P2B (57)
PI3K/MTOR INHIBITOR LY3023414
Non-Hodgkin Lymphoma
National Cancer Institute (NCI)P2B (57)
PI3K/MTOR INHIBITOR LY3023414
Langerhans Cell Histiocytosis
National Cancer Institute (NCI)P2B (57)
PI3K/MTOR INHIBITOR LY3023414
Malignant Glioma
National Cancer Institute (NCI)P2B (57)
PI3K/MTOR INHIBITOR LY3023414
Rhabdomyosarcoma
National Cancer Institute (NCI)P2B (57)
PI3K/MTOR INHIBITOR LY3023414
Ependymoma
National Cancer Institute (NCI)P2B (57)
PI3K/MTOR INHIBITOR LY3023414
Ewing Sarcoma
National Cancer Institute (NCI)P2B (57)
PI3K/MTOR INHIBITOR LY3023414
Glioma
National Cancer Institute (NCI)P2B (57)
PI3K/MTOR INHIBITOR LY3023414
Hepatoblastoma
National Cancer Institute (NCI)P2B (57)
PI3K/MTOR INHIBITOR LY3023414
Malignant Germ Cell Tumor
National Cancer Institute (NCI)P2B (57)
PI3K/MTOR INHIBITOR LY3023414
Medulloblastoma
National Cancer Institute (NCI)P2B (57)
PI3K/MTOR INHIBITOR LY3023414
Neuroblastoma
National Cancer Institute (NCI)P2B (57)
PI3K/MTOR INHIBITOR LY3023414
Osteosarcoma
National Cancer Institute (NCI)P2B (57)
PI3K/MTOR INHIBITOR LY3023414
Peripheral Primitive Neuroectodermal Tumor
National Cancer Institute (NCI)P2B (57)
Showing 826 to 850 of 3,272 assets
PreviousPage 34 of 131Next